The Frost & Sullivan Technological Innovation Award is given to companies engaged in innovative research leading to developments expected to contribute significantly to the industry
Orsens won today the technological innovation award for 2006 awarded by the Frost & Sullivan company for the development of a non-invasive system for continuous monitoring of the blood sugar level. The system is based on an innovative technology from the Orsens company that allows non-invasive and highly sensitive measurement of the concentrations of various blood components such as sugar, hemoglobin, red blood cells and oxygen saturation, as well as measurement of the heart rate.
Blood sugar monitoring plays a central role in the treatment of diabetes, because frequent measurements are essential for effective treatment of the disease. In recent years, there has been a dramatic increase in the incidence of the disease, and as a result a large number of patients need a convenient and effective method of self-monitoring of their blood sugar level, monitoring that allows them to lead a healthy life despite the disease. The method available today is invasive and involves frequent pricking of the finger. This method is not convenient and does not allow continuous measurements. Therefore, there is a need to develop an alternative method that is not invasive. Orsens' non-invasive technology for measuring blood sugar is expected, therefore, to significantly improve the quality of treatment for diabetes patients and their quality of life.
"We are proud to receive the Frost & Sullivan Technological Innovation Award for 2006. Our non-invasive system for continuous blood sugar measurement has been tested on more than 350 people so far, and has been found to be as accurate as the invasive methods available today and at the same time more convenient and safer to use. We intend to submit the device for approval by the regulatory bodies during 2007 and market it about a year later," said Lior Mein, CEO of Orsense. "We are currently developing the second generation of the device, which is designed to achieve even higher levels of accuracy. The device will allow any person with diabetes to check their sugar level by themselves, continuously or intermittently, during the day, without harming their normal lifestyle," concluded Mr. Mein.
Frost & Sullivan is an international consulting company that monitors the medical device industry, and locates companies that demonstrate excellence, persistence, commitment and innovative business strategies that lead to success in the global market. The Frost & Sullivan Technological Innovation Award is given to companies engaged in innovative research leading to developments that are expected to contribute significantly to the industry. In choosing the winning company, the quality of the company's research and development as well as the vision and level of risk that made the breakthrough possible are taken into account.
About Orsense
Orsense is a medical device company that develops a non-invasive test to measure blood sugar. The company's products are based on unique optical technology. Orsens also develops and markets non-invasive products for measuring other important blood components, such as hemoglobin. Orsens has 20 approved patents, and over 25 patent applications. Israel Health Care Ventures and STAR are among the venture capital funds invested in the company. More information is available On the company's website.
The International Diabetes Institute: "The award received by Orsens is a breakthrough that will allow diabetics to control their disease and adapt their diet to their condition" Dr. Haim Lavi, the medical director of the International Diabetes Institute, who treats diabetics (type 2) using the "Amkod" method, said after receiving The award: "The Orsens system is a breakthrough and a big step forward for diabetics. Monitoring the blood sugar level is a very significant element in the treatment of diabetes, because frequent measurements are essential for effective treatment of the disease."
"Today," explains Dr. Lavi, "when using the Amkod method diabetics can actually beat the disease and return to a normal life without drugs, through intensive treatment that combines dietary change, targeted physical activity and treatment with a unique formula of medicinal plants, the Orsense system is of particular importance . The system will allow diabetics who were treated with the Amkod method and have returned to a normal life without medication, to monitor their blood sugar levels in a simple procedure, and thus see if they need to change their diet again or if they are still within the safe limits of the blood sugar level. Hats off to the people of Orsense, who made life significantly easier for the diabetic public."
